We are proud to announce that Defytime Holdings, a new company that is focused on discovering a radical cure to Telomerase Enzyme Deficiency Syndrome (TEDS), has chosen Fanfare as official Social Commerce Partner. As a part of this partnership, Fanfare will shed light on Defytime’s work and raise awareness on TEDS on our Social Platforms, and also boost a selection of Telomere products on our eshop.
Defytime Holdings seeks to curing diseases associated with human aging, including the aging process itself. TEDS is present in almost 100% of humans, and it can lead to arthritis, Alzheimer’s, osteoporosis, cardiovascular disease, and many other age related diseases. It has been found that aging can be cured by lengthening telomeres via telomerase.
We recognize the work and difference that Defytime is striving to make in this world. Being the world’s first Blockchain-powered Social Commerce platform that seeks to bridge the gap between brands and consumers, if this can shed light on Defytime’s work and raise awareness on TEDS — we are all for it.
For more info on Defytime — http://defytime.com/
We are delighted to announce that LDJ Capital has inked a strategic partnership alliance with us for fund-raising, project development and business expansion. LDJ Capital is a multi-family office which deals in worldwide funds accessing over trillions in assets and maintains over 50+ global directors and family office partners. Read More